NM_145038.5:c.1069A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_145038.5(DRC1):​c.1069A>G​(p.Lys357Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,614,000 control chromosomes in the GnomAD database, including 24,958 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2080 hom., cov: 32)
Exomes 𝑓: 0.17 ( 22878 hom. )

Consequence

DRC1
NM_145038.5 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.89

Publications

27 publications found
Variant links:
Genes affected
DRC1 (HGNC:24245): (dynein regulatory complex subunit 1) This gene encodes a central component of the nexin-dynein complex (N-DRC), which regulates the assembly of ciliary dynein. Mutations in this gene can cause ciliary dyskinesia. [provided by RefSeq, Aug 2015]
DRC1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 21
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 80
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059809983).
BP6
Variant 2-26444262-A-G is Benign according to our data. Variant chr2-26444262-A-G is described in ClinVar as [Benign]. Clinvar id is 402796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC1NM_145038.5 linkc.1069A>G p.Lys357Glu missense_variant Exon 9 of 17 ENST00000288710.7 NP_659475.2 Q96MC2
DRC1XM_047446339.1 linkc.49A>G p.Lys17Glu missense_variant Exon 2 of 10 XP_047302295.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DRC1ENST00000288710.7 linkc.1069A>G p.Lys357Glu missense_variant Exon 9 of 17 2 NM_145038.5 ENSP00000288710.2 Q96MC2

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22187
AN:
152098
Hom.:
2074
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0326
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.217
Gnomad EAS
AF:
0.217
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.263
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.174
Gnomad OTH
AF:
0.166
GnomAD2 exomes
AF:
0.190
AC:
47660
AN:
251296
AF XY:
0.190
show subpopulations
Gnomad AFR exome
AF:
0.0277
Gnomad AMR exome
AF:
0.235
Gnomad ASJ exome
AF:
0.215
Gnomad EAS exome
AF:
0.225
Gnomad FIN exome
AF:
0.259
Gnomad NFE exome
AF:
0.174
Gnomad OTH exome
AF:
0.195
GnomAD4 exome
AF:
0.172
AC:
251588
AN:
1461786
Hom.:
22878
Cov.:
33
AF XY:
0.173
AC XY:
125674
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0259
AC:
866
AN:
33478
American (AMR)
AF:
0.228
AC:
10206
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5618
AN:
26132
East Asian (EAS)
AF:
0.195
AC:
7751
AN:
39700
South Asian (SAS)
AF:
0.197
AC:
16957
AN:
86248
European-Finnish (FIN)
AF:
0.254
AC:
13565
AN:
53386
Middle Eastern (MID)
AF:
0.163
AC:
942
AN:
5768
European-Non Finnish (NFE)
AF:
0.166
AC:
185101
AN:
1111986
Other (OTH)
AF:
0.175
AC:
10582
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
11933
23866
35799
47732
59665
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6526
13052
19578
26104
32630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.146
AC:
22195
AN:
152214
Hom.:
2080
Cov.:
32
AF XY:
0.152
AC XY:
11298
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0325
AC:
1349
AN:
41562
American (AMR)
AF:
0.175
AC:
2671
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.217
AC:
753
AN:
3472
East Asian (EAS)
AF:
0.217
AC:
1122
AN:
5180
South Asian (SAS)
AF:
0.212
AC:
1020
AN:
4820
European-Finnish (FIN)
AF:
0.263
AC:
2783
AN:
10568
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.174
AC:
11846
AN:
68014
Other (OTH)
AF:
0.171
AC:
361
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
944
1888
2833
3777
4721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.166
Hom.:
10033
Bravo
AF:
0.135
TwinsUK
AF:
0.152
AC:
565
ALSPAC
AF:
0.153
AC:
589
ESP6500AA
AF:
0.0354
AC:
156
ESP6500EA
AF:
0.171
AC:
1473
ExAC
AF:
0.184
AC:
22338
Asia WGS
AF:
0.269
AC:
933
AN:
3478
EpiCase
AF:
0.176
EpiControl
AF:
0.175

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 21 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0089
T
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.9
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.059
Sift
Uncertain
0.0040
D
Sift4G
Benign
0.14
T
Polyphen
0.92
P
Vest4
0.34
MPC
0.26
ClinPred
0.025
T
GERP RS
4.2
Varity_R
0.30
gMVP
0.10
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3795958; hg19: chr2-26667130; COSMIC: COSV56531648; COSMIC: COSV56531648; API